Extendicare Stock Price Prediction
| EXE Stock | CAD 10.33 0.03 0.29% |
Oversold Vs Overbought
76
Oversold | Overbought |
Quarterly Earnings Growth 13.5 | EPS Estimate Current Year 0.8 | EPS Estimate Next Year 0.69 | Wall Street Target Price 10.5 | Quarterly Revenue Growth 0.133 |
Using Extendicare hype-based prediction, you can estimate the value of Extendicare from the perspective of Extendicare response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Extendicare to buy its stock at a price that has no basis in reality. In that case, they are not buying Extendicare because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Extendicare after-hype prediction price | CAD 10.32 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Extendicare |
Extendicare After-Hype Price Prediction Density Analysis
As far as predicting the price of Extendicare at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Extendicare or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Extendicare, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Extendicare Estimiated After-Hype Price Volatility
In the context of predicting Extendicare's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Extendicare's historical news coverage. Extendicare's after-hype downside and upside margins for the prediction period are 8.76 and 11.88, respectively. We have considered Extendicare's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Extendicare is not too volatile at this time. Analysis and calculation of next after-hype price of Extendicare is based on 3 months time horizon.
Extendicare Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Extendicare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Extendicare backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Extendicare, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.31 | 1.56 | 0.01 | 0.00 | 4 Events / Month | 1 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
10.33 | 10.32 | 0.10 |
|
Extendicare Hype Timeline
Extendicare is currently traded for 10.33on Toronto Exchange of Canada. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.0. Extendicare is forecasted to decline in value after the next headline, with the price expected to drop to 10.32. The average volatility of media hype impact on the company price is over 100%. The price drop on the next news is expected to be -0.1%, whereas the daily expected return is currently at 0.31%. The volatility of related hype on Extendicare is about 52000.0%, with the expected price after the next announcement by competition of 10.33. About 14.0% of the company shares are held by company insiders. The company last dividend was issued on the 31st of October 2024. Extendicare had 43:40 split on the 10th of November 2006. Assuming the 90 days trading horizon the next forecasted press release will be in about 4 days. Check out Extendicare Basic Forecasting Models to cross-verify your projections.Extendicare Related Hype Analysis
Having access to credible news sources related to Extendicare's direct competition is more important than ever and may enhance your ability to predict Extendicare's future price movements. Getting to know how Extendicare's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Extendicare may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SOLR | Solar Alliance Energy | 0.00 | 1 per month | 8.17 | 0.02 | 25.00 | (20.00) | 50.00 | |
| BES | Braille Energy Systems | 0 | 1 per month | 0.00 | (0.06) | 7.14 | (7.14) | 27.88 | |
| MIR | MedMira | 0.01 | 1 per month | 0.00 | (0.05) | 12.50 | (11.11) | 23.61 | |
| LTE | Lite Access Technologies | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MN | Manganese X Energy | 0.00 | 1 per month | 0.00 | (0.04) | 11.11 | (20.00) | 50.00 |
Extendicare Additional Predictive Modules
Most predictive techniques to examine Extendicare price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Extendicare using various technical indicators. When you analyze Extendicare charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Extendicare Predictive Indicators
The successful prediction of Extendicare stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Extendicare, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Extendicare based on analysis of Extendicare hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Extendicare's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Extendicare's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0654 | 0.0729 | 0.0663 | 0.0746 | Price To Sales Ratio | 0.54 | 0.48 | 0.47 | 0.43 |
Story Coverage note for Extendicare
The number of cover stories for Extendicare depends on current market conditions and Extendicare's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Extendicare is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Extendicare's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Extendicare Short Properties
Extendicare's future price predictability will typically decrease when Extendicare's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Extendicare often depends not only on the future outlook of the potential Extendicare's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Extendicare's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 85 M | |
| Cash And Short Term Investments | 75.9 M |
Other Information on Investing in Extendicare Stock
Extendicare financial ratios help investors to determine whether Extendicare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.